Literature DB >> 14630820

Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133.

Sergey V Shmelkov1, Lin Jun, Ryan St Clair, Deirdre McGarrigle, Christopher A Derderian, Jaroslav K Usenko, Carla Costa, Fan Zhang, Xinzheng Guo, Shahin Rafii.   

Abstract

AC133 is a member of a novel family of cell surface proteins with 5 transmembrane domains. The function of AC133 is unknown. Although AC133 mRNA is detected in different tissues, its expression in the hematopoietic system is restricted to CD34+ stem cells. AC133 is also expressed on stem cells of other tissues, including endothelial progenitor cells. However, despite the potential importance of AC133 to the field of stem cell biology, nothing is known about the transcriptional regulation of AC133 expression. In this report we showed that the human AC133 gene has at least 9 distinctive 5'-untranslated region (UTR) exons, resulting in the formation of at least 7 alternatively spliced 5'-UTR isoforms of AC133 mRNA, which are expressed in a tissue-dependent manner. We found that transcription of these AC133 isoforms is controlled by 5 alternative promoters, and we demonstrated their activity on AC133-expressing cell lines using a luciferase reporter system. We also showed that in vitro methylation of 2 of these AC133 promoters completely suppresses their activity, suggesting that methylation plays a role in their regulation. Identification of tissue-specific AC133 promoters may provide a novel method to isolate tissue-specific stem and progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630820     DOI: 10.1182/blood-2003-06-1881

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

1.  Isolation of renal progenitor cells from adult human kidney.

Authors:  Benedetta Bussolati; Stefania Bruno; Cristina Grange; Stefano Buttiglieri; Maria Chiara Deregibus; Dario Cantino; Giovanni Camussi
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

2.  The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.

Authors:  Donald J Vander Griend; Wouter L Karthaus; Susan Dalrymple; Alan Meeker; Angelo M DeMarzo; John T Isaacs
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

3.  CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116.

Authors:  Claudia Dittfeld; Antje Dietrich; Susann Peickert; Sandra Hering; Michael Baumann; Marian Grade; Thomas Ried; Leoni A Kunz-Schughart
Journal:  Radiother Oncol       Date:  2010-03       Impact factor: 6.280

4.  Control of AC133/CD133 and impact on human hematopoietic progenitor cells through nucleolin.

Authors:  S Bhatia; S Reister; C Mahotka; R Meisel; A Borkhardt; E Grinstein
Journal:  Leukemia       Date:  2015-06-19       Impact factor: 11.528

5.  Promoter hypermethylation and loss of CD133 gene expression in colorectal cancers.

Authors:  You-Kyung Jeon; Sung-Hee Kim; Seung-Ho Choi; Kyung-Hee Kim; Byong-Chul Yoo; Ja-Lok Ku; Jae-Gahb Park
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

6.  Identification and characterization of a novel scFv recognizing human and mouse CD133.

Authors:  Suresh Kumar Swaminathan; Lin Niu; Nate Waldron; Steve Kalscheuer; David M Zellmer; Michael R Olin; John R Ohlfest; Daniel A Vallera; Jayanth Panyam
Journal:  Drug Deliv Transl Res       Date:  2013-04       Impact factor: 4.617

7.  Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer.

Authors:  Tianyun Jiang; Brendan J Collins; Ning Jin; David N Watkins; Malcolm V Brock; William Matsui; Barry D Nelkin; Douglas W Ball
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

Review 8.  CD133: to be or not to be, is this the real question?

Authors:  Elena Irollo; Giuseppe Pirozzi
Journal:  Am J Transl Res       Date:  2013-09-25       Impact factor: 4.060

9.  Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors.

Authors:  Joo Mi Yi; Hsing-Chen Tsai; Sabine C Glöckner; Steven Lin; Joyce E Ohm; Hari Easwaran; C David James; Joseph F Costello; Gregory Riggins; Charles G Eberhart; John Laterra; Angelo L Vescovi; Nita Ahuja; James G Herman; Kornel E Schuebel; Stephen B Baylin
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

10.  Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks.

Authors:  Kouichi Tabu; Taichi Kimura; Ken Sasai; Lei Wang; Norihisa Bizen; Hiroshi Nishihara; Tetsuya Taga; Shinya Tanaka
Journal:  Mol Cancer       Date:  2010-02-19       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.